Myocardial fibrosis is associated with adverse left ventricular remodelling and heart failure hospitalisations in anthracycline-treated cancer survivors at 5 years follow-up

2 May 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Iwan Benjamin Harries

Bristol Heart Institute, Bristol (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail

Genotypic groups as risk factor for cardiac MR abnormalities and complications in thalassemia major

Doctor A. Pepe (Pisa, IT)

Abstract Slides

Presentation thumbnail

Cardiac magnetic resonance detects early cardiac involvement in HIV patients: oedema and inflammation, which may be reversible with therapy

Doctor A. Seraphim (Nicosia, CY)

Abstract Slides

Presentation thumbnail

Cardiac involvement of Wilsons disease. A myocardial strain and imaging study.

Presentation thumbnail

Myocardial fibrosis is a predictor of atrial fibrillation in dilated cardiomyopathy- role of cardiovascular magnetic resonance

Doctor J. Rigueira (Lisbon, PT)

Abstract Slides

Presentation thumbnail

Left ventricular dysfunction, not myocardial injury, drives use of cardioprotective medications in acute myocarditis: insights from machine learning

Assistant Professor A. Cardona (Todi, IT)

Access the full session

Session thumbnail

Moderated ePosters session 5: tissue characterisation in non-ischaemic heart disease

The Event

EuroCMR 2019

2 May - 4 May 2019

You may be interested in

Congress Presentation

Magnetic resonance imaging is the way to go for risk assessment

Congress Presentation

Cardiac magnetic resonance imaging in the work-up and management of cardiac amyloidosis

Congress Presentation

CMR for inflammation, oedema, and the pericardium

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources